5don MSN
New clues to hepatitis B species restriction could help build a novel model for studying infection
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...
A recent study published in Alimentary Pharmacology and Therapeutics reports that patients with a lower hepatitis B virus (HBV) haplotype number of less than or equal to two are more likely to achieve ...
Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other ...
Hepatitis B virus (HBV) causes hepatitis B. Worldwide, hepatitis B is thought to be the second deadliest infection; it's estimated that about five percent of the global population have the disease.
As part of their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) can establish an infection in liver cells, researchers led by teams at Memorial Sloan ...
ELIMINATE-B Phase 1 dose finding study for chronic Hepatitis B executing on schedule with completion of first dose administration for cohort 1 (n=3 patients) PBGENE-HBV, the first LNP gene editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results